Possible Administrative Guidance against 株式会社こころ
For developers: integration details
You do not need this for normal browsing. Use it when integrating this enforcement record into an internal tool or AI workflow.
/api/v1/enforcements?company=%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE%E3%81%93%E3%81%93%E3%82%8D&limit=10Action summary
- Company
- 株式会社こころJapanese originalOriginal: 株式会社こころ
- Entity match
- Possible entity match60/100Machine extractedCompany name extracted from the Japanese public disclosure
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices薬機法
- Action type
- Administrative Guidance行政指導
- Action date
- 28 July 2020
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Based on the submission of two types of CBD products, a total of eight products, the ingredients were analyzed. The analysis revealed that three units of CBD Oil Pro900 (10 mL capacity) and two units of CBD Oil Pro2700 (30 mL capacity) contained trace amounts of the cannabis component THC.
Show original Japanese text
同社が回収したCBD製品２種類８製品の提出を受け、成分の分析を行いました。分析の結果、CBDオイルPro900（容量10mL）3製品、CBDオイルPro2700（容量30mL）2製品から、微量の大麻成分THCが検出されました。
Compliance context
Low-mediumAdministrative guidance or supervision was publicly disclosed by the authority.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Use as a monitoring signal. Confirm details before treating it as a formal sanction.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-04-24T23:36:55.242+00:00
- Evidence checked
- 2026-04-24T23:36:55.242+00:00
- Archive captured
- 2026-04-03T12:30:55.3+00:00
Show audit JSON
{
"record": {
"id": "3d17ca96-f359-4238-8483-8e050e1123ed",
"url": "https://regbase.jp/en/enforcement/yakkiho-kokoro-20200728",
"company_name_original": "株式会社こころ",
"company_name_registry": "株式会社こころ",
"corporate_number": null,
"law": {
"ja": "薬機法",
"en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
},
"action_type": {
"ja": "行政指導",
"en": "Administrative Guidance"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "possible",
"confidence": 60,
"method": "extracted_japanese_name",
"method_label": "Company name extracted from the Japanese public disclosure",
"notes": null
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Low-medium",
"actionMeaning": "Administrative guidance or supervision was publicly disclosed by the authority.",
"practicalNote": "Use as a monitoring signal. Confirm details before treating it as a formal sanction.",
"lawContext": "Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/yakkiho-kokoro-20200728",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_12615.html",
"archiveUrl": "https://kiroku.today/view/11781e85a3ivtu6e",
"archiveCapturedAt": "2026-04-03T12:30:55.3+00:00",
"extractedAt": "2026-04-24T23:36:55.242+00:00",
"translatedAt": "2026-05-01T06:51:27.635+00:00",
"evidenceCheckedAt": "2026-04-24T23:36:55.242+00:00",
"generatedAt": "2026-06-19T09:09:49.584Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.